investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

CRC Tier 1 - Determining why mutations of the metabolic enzyme isocitrate dehydrogenase cause leukemias and brain cancers

Tak Mak

0 Collaborator(s)

Funding source

Canadian Institutes of Health Research (CIHR)

Tak Mak

University of Toronto

Toronto, Canada

Related projects

Aaron David Schimmer

Targeting mitochondrial translation as a novel therapeutic strategy for AML

Leukaemia

Andrew Weng

Regulation of Leukemia Stem Cell Activity by Signaling through PKC[theta]

Leukaemia

Crystal Mackall

Immunobiology and Immunotherapy of Pediatric Cancer

Leukaemia

Pediatric oncology or childhood cancer

Paul Miller

Regulation of human hematopoietic cells with rapid in vivo repopulating activity

Leukaemia

Peter Aplan

Activation of Proto-Oncogenes by Chromosomal Translocation

Leukaemia

Hematology and hematologic malignancies Pathology

Peter Blumberg

Molecular Mechanism of Action of Phorbol Ester

Leukaemia

Katherine Warren

Preclinical Evaluation of Novel Therapeutics for CNS Tumor Therapy

Brain, nervous system

Brent Williams

Immunotherapy of leukemic stem cells

Leukaemia

Monica J Justice

The Pluripotency Regulator Prdm14 Initiates Cancer by Epigenetic Mechanisms

Leukaemia

Pathology Hematology and hematologic malignancies